2
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Not yet recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Conditions
Neoplasms
15
Lung Neoplasms
11
Colonic Neoplasms
10
Breast Neoplasms
9
Brain Neoplasms
7
Prostatic Neoplasms
4
Emergence Delirium
4
Urinary Bladder Neoplasms
3
Stomach Neoplasms
3
Respiratory Aspiration
3
Rectal Neoplasms
3
Pituitary Neoplasms
3
Neoplastic Cells, Circulating
3
Hypoxia
3
Carcinoma, Non-Small-Cell Lung
3
Carcinoma, Hepatocellular
3
Agnosia
3
Supratentorial Neoplasms
2
Postoperative Complications
2
Patient Satisfaction
2
Pain, Postoperative
2
Pain
2
Ovarian Neoplasms
2
Neoplasm Metastasis
2
Melanoma
2
Liver Neoplasms
2
Leukemia
2
Delirium
2
Colorectal Neoplasms
2
Abdominal Neoplasms
2
Interventions
Dexamethasone
4
Electroencephalography
3
XENP 1595
2
Methods
2
selinexor
1
pomalidomide
1
ixazomib
1
fasudil
1
birtamimab
1
UE2343
1
Transurethral Resection of Bladder
1
Telemedicine
1
Tablets
1
Surgical Procedures, Operative
1
Standard of Care
1
Rosiglitazone
1
Propofol
1
Positron-Emission Tomography
1
Neurofeedback
1
Methotrexate
1
Melphalan
1
Mass Screening
1
Magnetic Resonance Imaging
1
Lysine Acetyltransferase 5
1
Hypnosis
1
Hormones
1
Exercise
1
Ethanol
1
Drug Delivery Systems
1
Donepezil
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Alzheimer Disease
×
Propofol
×
Clear all
NCT06644573
2025-05-28
PSHW
PROSOMNIA Sleep Health & Wellness
Phase 1
Not yet recruiting
100 enrolled